Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

A high risk high reward Finnish AI-stock, but not for your grandmothers portfolio

By Antti LuiroHead of Nordic ER Development, Analyst
Aiforia Technologies

Aiforia is a software company at a commercially early stage whose products enable AI-based image analysis in medicine. The software's primary application is in pathology, where it helps pathologists analyze tissue samples taken from patients. Analyst Antti Luiro comments.

Read the extensive report here https://www.inderes.se/research/aiforia-promisingly-started-growth-journey-just-beginning

Follow Aiforia https://www.inderes.se/companies/Aiforia-Technologies

00:00 Intro
00:27 The big problem Aiforia tries to solve
02:45 How does Aiforia make money?
04:10 Market potential
10:50 Business stickiness
13:35 Dilution risk
16:00 Investment case

Recent videos

Surgical Science Sweden, Capital Markets Day, CMD, 2025
08.12.2025, 14.00 Surgical Science Sweden
HCA Morgenbørs 08/12 - Små fald i futures og fokus på Gubra, Genmab og Lundbeck
08.12.2025, 09.24 Genmab
AKTIER MED FRIIS - UGE 49 2025
05.12.2025, 12.00
HCA Morgenbørs 05/12 - Overvejende positive futures-markeder hvor kun Japan er i minus
05.12.2025, 09.20 GreenMobility
GreenMobility: What is the investment case in driverless cars
05.12.2025, 08.00 GreenMobility
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.